Arcus Biosciences (RCUS) PT Lowered to $30 at Wedbush
Tweet
Share
E-mailGet Alerts RCUS Hot Sheet
Price: $30.35 --0%
Rating Summary:
12 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 10 | New: 19
Rating Summary:
12 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 10 | New: 19
Join SI Premium – FREE
Wedbush analyst Robert Driscoll lowered the price target on Arcus Biosciences (NYSE: RCUS) to $30.00 (from $36.00) while maintaining a Outperform rating.
You May Also Be Interested In
- JPMorgan Upgrades Hong Kong & China Gas (3:HK) (HOKCY) to Overweight
- Shizuoka Financial Group Inc (5831:JP) PT Raised to JPY4,270 at JPMorgan
- Bendigo & Adelaide Bank Ltd (BEN:AU) (BXRBF) PT Lowered to AUD10.50 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
